{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?city=Louisville&page=47&state=Kentucky", "query": { "state": "Kentucky", "city": "Louisville", "page": 47 }, "page_size": 10 }, "pagination": { "page": 47, "page_size": 10, "total_count": 5305, "total_pages": 531, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?city=Louisville&page=48&state=Kentucky&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?city=Louisville&page=46&state=Kentucky&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-31T00:43:15.197Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT00689117", "title": "A Clinical Study to Evaluate the Safety and Effectiveness of an Investigational Product Called CT Gel", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Acne Vulgaris", "Acne" ], "interventions": [ { "name": "CT Gel", "type": "DRUG" }, { "name": "Clindamycin Gel (clindamycin )", "type": "DRUG" }, { "name": "Tretinoin Gel (tretinoin)", "type": "DRUG" }, { "name": "Vehicle Gel", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Stiefel, a GSK Company", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": null, "sex": "ALL", "summary": "12 Years and older" }, "enrollment_count": 1649, "start_date": "2008-04", "completion_date": "2009-05", "has_results": true, "last_update_posted_date": "2017-05-30", "last_synced_at": "2026-10-31T00:43:15.197Z", "location_count": 27, "location_summary": "Birmingham, Alabama • Mobile, Alabama • Hot Springs, Arkansas + 24 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Mobile", "state": "Alabama" }, { "city": "Hot Springs", "state": "Arkansas" }, { "city": "Fremont", "state": "California" }, { "city": "San Diego", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00689117" }, { "nct_id": "NCT03092674", "title": "Azacitidine With or Without Nivolumab or Midostaurin, or Decitabine and Cytarabine Alone in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2", "PHASE3" ], "conditions": [ "Acute Myeloid Leukemia", "Myelodysplastic Syndrome", "Myelodysplastic Syndrome/Acute Myeloid Leukemia" ], "interventions": [ { "name": "Azacitidine", "type": "DRUG" }, { "name": "Cytarabine", "type": "DRUG" }, { "name": "Decitabine", "type": "DRUG" }, { "name": "Laboratory Biomarker Analysis", "type": "OTHER" }, { "name": "Midostaurin", "type": "DRUG" }, { "name": "Nivolumab", "type": "BIOLOGICAL" } ], "intervention_types": [ "DRUG", "OTHER", "BIOLOGICAL" ], "sponsor": "National Cancer Institute (NCI)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "60 Years", "maximum_age": null, "sex": "ALL", "summary": "60 Years and older" }, "enrollment_count": 76, "start_date": "2018-02-02", "completion_date": "2024-06-26", "has_results": true, "last_update_posted_date": "2025-01-16", "last_synced_at": "2026-10-31T00:43:15.197Z", "location_count": 506, "location_summary": "Anchorage, Alaska • Tucson, Arizona • Hot Springs, Arkansas + 337 more", "locations": [ { "city": "Anchorage", "state": "Alaska" }, { "city": "Anchorage", "state": "Alaska" }, { "city": "Anchorage", "state": "Alaska" }, { "city": "Anchorage", "state": "Alaska" }, { "city": "Anchorage", "state": "Alaska" } ], "official_url": "https://clinicaltrials.gov/study/NCT03092674" }, { "nct_id": "NCT01187368", "title": "Prospective Multi-Center Randomized Study for Evaluating the EVAHEART®2 Left Ventricular Assist System", "overall_status": "SUSPENDED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Heart Failure" ], "interventions": [ { "name": "EVAHEART Left Ventricular Assist System (LVAS)", "type": "DEVICE" }, { "name": "HeartMate 3", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Evaheart, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 399, "start_date": "2020-03-31", "completion_date": "2028-07-31", "has_results": false, "last_update_posted_date": "2026-03-27", "last_synced_at": "2026-10-31T00:43:15.197Z", "location_count": 12, "location_summary": "Gainesville, Florida • Tampa, Florida • Indianapolis, Indiana + 9 more", "locations": [ { "city": "Gainesville", "state": "Florida" }, { "city": "Tampa", "state": "Florida" }, { "city": "Indianapolis", "state": "Indiana" }, { "city": "Louisville", "state": "Kentucky" }, { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT01187368" }, { "nct_id": "NCT01244191", "title": "Tivantinib Plus Erlotinib Versus Placebo Plus Erlotinib for the Treatment of Non-squamous, Non-small-cell Lung Cancer", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Non Squamous, Non-small-cell Lung Cancer" ], "interventions": [ { "name": "Tivantinib", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "Erlotinib", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Daiichi Sankyo", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 1048, "start_date": "2011-01-11", "completion_date": "2012-12-15", "has_results": true, "last_update_posted_date": "2021-04-06", "last_synced_at": "2026-10-31T00:43:15.197Z", "location_count": 111, "location_summary": "Tucson, Arizona • Los Angeles, California • Oxnard, California + 85 more", "locations": [ { "city": "Tucson", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Los Angeles", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01244191" }, { "nct_id": "NCT05021835", "title": "ZEUS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Cardiovascular Disease, Chronic Kidney Disease and Inflammation", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Cardiovascular Risk", "Chronic Kidney Disease", "Inflammation" ], "interventions": [ { "name": "Ziltivekimab B", "type": "DRUG" }, { "name": "Ziltivekimab C", "type": "DRUG" }, { "name": "Placebo (Ziltivekimab B)", "type": "DRUG" }, { "name": "Placebo (Ziltivekimab C)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Novo Nordisk A/S", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 6385, "start_date": "2021-08-30", "completion_date": "2026-06-09", "has_results": false, "last_update_posted_date": "2026-09-28", "last_synced_at": "2026-10-31T00:43:15.197Z", "location_count": 181, "location_summary": "Birmingham, Alabama • Montgomery, Alabama • Glendale, Arizona + 140 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Montgomery", "state": "Alabama" }, { "city": "Glendale", "state": "Arizona" }, { "city": "Mesa", "state": "Arizona" }, { "city": "Little Rock", "state": "Arkansas" } ], "official_url": "https://clinicaltrials.gov/study/NCT05021835" }, { "nct_id": "NCT02536118", "title": "Micra Transcatheter Pacing System Post-Approval Registry", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Bradycardia" ], "interventions": [ { "name": "Micra Transcatheter Pacing System", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Medtronic", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "ALL", "summary": "Not listed" }, "enrollment_count": 3100, "start_date": "2015-07", "completion_date": "2027-04", "has_results": false, "last_update_posted_date": "2026-02-04", "last_synced_at": "2026-10-31T00:43:15.197Z", "location_count": 52, "location_summary": "Birmingham, Alabama • Los Angeles, California • Redwood City, California + 49 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Los Angeles", "state": "California" }, { "city": "Redwood City", "state": "California" }, { "city": "New Haven", "state": "Connecticut" }, { "city": "Washington D.C.", "state": "District of Columbia" } ], "official_url": "https://clinicaltrials.gov/study/NCT02536118" }, { "nct_id": "NCT00643409", "title": "A Multicenter, Randomized, Double-Blind, Double-Dummy Trial of Azithromycin SR Compared With Levofloxacin for the Treatment of Sinus Infections in Adults", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Maxillary Sinusitis" ], "interventions": [ { "name": "azithromycin SR (Zithromax; compound: CP-62,993)", "type": "DRUG" }, { "name": "placebo", "type": "OTHER" }, { "name": "levofloxacin", "type": "DRUG" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 541, "start_date": "2003-01", "completion_date": "2004-02", "has_results": false, "last_update_posted_date": "2011-05-11", "last_synced_at": "2026-10-31T00:43:15.197Z", "location_count": 59, "location_summary": "Alabaster, Alabama • Birmingham, Alabama • Hueytown, Alabama + 37 more", "locations": [ { "city": "Alabaster", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Hueytown", "state": "Alabama" } ], "official_url": "https://clinicaltrials.gov/study/NCT00643409" }, { "nct_id": "NCT06500455", "title": "Testing Longer Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With Cancer That Has Spread to the Brain", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Anatomic Stage IV Breast Cancer AJCC v8", "Metastatic Breast Carcinoma", "Metastatic Digestive System Carcinoma", "Metastatic Lung Non-Small Cell Carcinoma", "Metastatic Malignant Neoplasm in the Brain", "Metastatic Malignant Solid Neoplasm", "Metastatic Melanoma", "Metastatic Renal Cell Carcinoma", "Stage IV Lung Cancer AJCC v8", "Stage IV Renal Cell Cancer AJCC v8" ], "interventions": [ { "name": "Computed Tomography", "type": "PROCEDURE" }, { "name": "Fractionated Stereotactic Radiation Therapy", "type": "RADIATION" }, { "name": "Magnetic Resonance Imaging", "type": "PROCEDURE" }, { "name": "Stereotactic Radiosurgery", "type": "RADIATION" } ], "intervention_types": [ "PROCEDURE", "RADIATION" ], "sponsor": "NRG Oncology", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 274, "start_date": "2024-12-12", "completion_date": "2033-06-30", "has_results": false, "last_update_posted_date": "2026-09-14", "last_synced_at": "2026-10-31T00:43:15.197Z", "location_count": 262, "location_summary": "Tucson, Arizona • Fort Smith, Arkansas • Little Rock, Arkansas + 189 more", "locations": [ { "city": "Tucson", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Fort Smith", "state": "Arkansas" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Anaheim", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT06500455" }, { "nct_id": "NCT04452955", "title": "A Study to Assess Safety and Efficacy of PRL3-Zumab in Patients With Solid Tumors", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Solid Tumor" ], "interventions": [ { "name": "PRL3-zumab", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Intra-IMMUSG Pte Ltd", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 51, "start_date": "2020-12-12", "completion_date": "2026-12-01", "has_results": false, "last_update_posted_date": "2026-04-22", "last_synced_at": "2026-10-31T00:43:15.197Z", "location_count": 5, "location_summary": "Scottsdale, Arizona • Fullerton, California • Los Angeles, California + 2 more", "locations": [ { "city": "Scottsdale", "state": "Arizona" }, { "city": "Fullerton", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Louisville", "state": "Kentucky" }, { "city": "Las Vegas", "state": "Nevada" } ], "official_url": "https://clinicaltrials.gov/study/NCT04452955" }, { "nct_id": "NCT00653432", "title": "Safety and Effectiveness of Monovisc® Injection for Osteoarthritis of the Knee", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Osteoarthritis" ], "interventions": [ { "name": "Monovisc®", "type": "DEVICE" }, { "name": "Saline", "type": "OTHER" } ], "intervention_types": [ "DEVICE", "OTHER" ], "sponsor": "Anika Therapeutics, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "35 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "35 Years to 75 Years" }, "enrollment_count": 369, "start_date": "2008-01", "completion_date": "2010-02", "has_results": true, "last_update_posted_date": "2023-07-11", "last_synced_at": "2026-10-31T00:43:15.197Z", "location_count": 30, "location_summary": "Hoover, Alabama • Mesa, Arizona • Phoenix, Arizona + 27 more", "locations": [ { "city": "Hoover", "state": "Alabama" }, { "city": "Mesa", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Burbank", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00653432" } ] }